A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Recurrent or Metastatic Breast Cancer
Interventions: DRUG: Mitoxantrone Hydrochloride Liposome Injection
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.